| 134427 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Water Microbiology Scheme - (QWAS)
Water Microbiology Scheme - (QWAS)
|
2021-03-01 |
|
|
| Tested property |
(SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial)) |
| Testing method |
(2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix) |
|
| 138199 |
United States |
Collaborative Testing Services
Collaborative Testing Services
|
CTS Agriculture Laboratory Proficiency (ALP) Program: Water
CTS Agriculture Laboratory Proficiency (ALP) Program: Water
|
2019-05-23 |
|
|
| Tested property |
(Sum Cations, SAR, ADJ-SAR) |
|
| 143893 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Cosmetics and Toiletries Scheme (COSMETICS)
Cosmetics and Toiletries Scheme (COSMETICS)
|
2021-02-25 |
|
|
| Test item |
(Quality of hand sanitizer -NEW 2021 - relevant to SARS-CoV-2) (Quality of face masks -NEW 2021 - relevant to SARS-CoV-2) |
| Tested property |
(Relevant to SARS-CoV-2 pandemic) (Relevant to SARS-CoV-2 pandemic) |
|
| 302644 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Environmental Hygiene Monitoring Scheme- HYGIENE
Environmental Hygiene Monitoring Scheme- HYGIENE
|
2021-09-06 |
|
|
| Test item |
(Surface testing (swab rinsate) for SARS-CoV-2 molecular) |
| Tested property |
(SARS-CoV-2) |
|
| 437169 |
Germany |
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
|
Virus Genome Detection – Coronaviruses
[Virusgenom-Nachweis – Coronaviren]
Virus Genome Detection – Coronaviruses
[Virusgenom-Nachweis – Coronaviren]
|
2020-04-15 |
|
|
| Remarks |
() - qualitative, SARS-CoV-2 (RNA) - quantitative, SARS-CoV-2 (RNA) - qualitative
Next Terms:
June) |
| Tested property |
(differentiation between SARS-CoV-2, MERS coronavirus and other human coronaviruses (samples which contain the SARS-CoV-2 and/or MERS coronavirus are inactivated)) |
|
| 690909 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
|
2020-06-09 |
|
|
| PT name |
(ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)) |
| Tested property |
(Requirements, testing, marking for COVID-19) |
|
| 690914 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
|
2020-09-16 |
|
|
| PT name |
(Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112) |
|
| 696054 |
Germany |
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
|
Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)
[Medical face masks (EN 14683) / filtering half masks (EN 149)]
Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)
[Medical face masks (EN 14683) / filtering half masks (EN 149)]
|
2020-12-18 |
|
|
| Remarks |
(PT relevant to SARS-CoV-2 virus / COVID-19) |
|
| 699949 |
United Kingdom |
UK NEQAS for Immunology, Immunochemistry & Allergy
UK NEQAS for Immunology, Immunochemistry & Allergy
|
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
|
2020-08-05 |
|
|
| PT name |
(UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies) |
| Tested property |
(SARS-CoV-2 / COVID-19 Antibodies) |
|
| 705717 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 705734 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation) |
| Scheme name in national language |
(EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação) |
|
| 705752 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - TLR Coronavírus (SARS-CoV2): antigen) |
| Scheme name in national language |
(EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 705758 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)) |
|
| 706310 |
Portugal |
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
|
SARS-CoV-2, PCR
[SARS-CoV-2, PCR]
SARS-CoV-2, PCR
[SARS-CoV-2, PCR]
|
2021-03-25 |
|
|
| PT name |
(SARS-CoV-2, PCR) |
| Scheme name in national language |
(SARS-CoV-2, PCR) |
| Tested property |
(SARS-CoV-2 virus) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2020-10-01 |
|
|
| PT name |
(SARS-CoV-2 Proficiency Testing Scheme) |
| Test item |
(SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) |
| Tested property |
(SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) |
| Testing method |
(The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.) |
|
| 789737 |
Australia |
RCPAQAP
RCPAQAP
|
Molecular Coronavirus SARS-CoV-2
Molecular Coronavirus SARS-CoV-2
|
2020-10-28 |
|
|
| PT name |
(Molecular Coronavirus SARS-CoV-2) |
| Tested property |
(Coronavirus SARS-CoV2) |
|
| 789879 |
Australia |
RCPAQAP
RCPAQAP
|
Molecular Respiratory Pathogens
Molecular Respiratory Pathogens
|
2020-10-28 |
|
|
| Tested property |
(Coronavirus (OC43, NL63, SARS-CoV-2)) |
|
| 790103 |
Australia |
RCPAQAP
RCPAQAP
|
Coronavirus SARS CoV-2 Antibodies
Coronavirus SARS CoV-2 Antibodies
|
2020-10-27 |
|
|
| PT name |
(Coronavirus SARS CoV-2 Antibodies) |
| Tested property |
(SARS CoV-2) |
|
| 790376 |
Australia |
RCPAQAP
RCPAQAP
|
PoCT: COVID-19 serology (IgG/IgM)
PoCT: COVID-19 serology (IgG/IgM)
|
2020-10-26 |
|
|
| PT name |
(PoCT: COVID-19 serology (IgG/IgM)) |
| Tested property |
(COVID-19 Serology) |
|
| 794057 |
Australia |
RCPAQAP
RCPAQAP
|
PHLN: SARS-CoV-2 and other coronaviruses
PHLN: SARS-CoV-2 and other coronaviruses
|
2020-10-23 |
|
|
| PT name |
(PHLN: SARS-CoV-2 and other coronaviruses) |
| Remarks |
(Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2.
Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.) |
| Tested property |
(Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated)) |
|
